2/20
05:35 pm
adap
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Bertrand William C JR
Low
Report
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Bertrand William C JR
2/20
05:35 pm
adap
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Brewer Joanna Elizabeth
Low
Report
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Brewer Joanna Elizabeth
2/20
05:33 pm
adap
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Lunger John
Low
Report
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Lunger John
2/20
05:32 pm
adap
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Piccina Cintia
Low
Report
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Piccina Cintia
2/20
05:32 pm
adap
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Norry Elliot
Low
Report
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Norry Elliot
2/20
05:30 pm
adap
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Rawcliffe Adrian
Low
Report
Form 4 Adaptimmune Therapeutics For: Feb 20 Filed by: Rawcliffe Adrian
2/14
09:32 am
adap
Form SCHEDULE 13G Adaptimmune Therapeutics Filed by: Two Seas Capital LP
Low
Report
Form SCHEDULE 13G Adaptimmune Therapeutics Filed by: Two Seas Capital LP
2/12
10:26 am
adap
Form SCHEDULE 13G/A Adaptimmune Therapeutics Filed by: BAILLIE GIFFORD & CO
Low
Report
Form SCHEDULE 13G/A Adaptimmune Therapeutics Filed by: BAILLIE GIFFORD & CO
2/11
04:40 pm
adap
Form SCHEDULE 13G/A Adaptimmune Therapeutics Filed by: Long Focus Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Adaptimmune Therapeutics Filed by: Long Focus Capital Management, LLC
1/17
09:18 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Norry Elliot
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Norry Elliot
1/17
09:17 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Lunger John
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Lunger John
1/17
09:16 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Bertrand William C JR
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Bertrand William C JR
1/17
09:15 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Rawcliffe Adrian
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 17 Filed by: Rawcliffe Adrian
1/17
03:08 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Norry Elliot
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Norry Elliot
1/17
03:00 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Lunger John
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Lunger John
1/17
02:50 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Bertrand William C JR
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Bertrand William C JR
1/17
02:42 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Rawcliffe Adrian
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Rawcliffe Adrian
1/15
04:20 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Rawcliffe Adrian
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Rawcliffe Adrian
1/15
04:19 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 15 Filed by: Piccina Cintia
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 15 Filed by: Piccina Cintia
1/15
04:17 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Norry Elliot
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Norry Elliot
1/15
04:16 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Lunger John
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Lunger John
1/15
04:15 pm
adap
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Bertrand William C JR
Low
Report
Form 4 Adaptimmune Therapeutics For: Jan 13 Filed by: Bertrand William C JR
1/15
04:01 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Bertrand William C JR
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Bertrand William C JR
1/15
03:56 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Piccina Cintia
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Piccina Cintia
1/15
03:50 pm
adap
Form 144 Adaptimmune Therapeutics Filed by: Norry Elliot
Low
Report
Form 144 Adaptimmune Therapeutics Filed by: Norry Elliot